A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 5, 2005, Pages 1371-1378

  Schefter, Tracey E ^a   Kavanagh, Brian D ^a   Timmerman, Robert D ^b   Cardenes, Higinia R ^c   Baron, Anna ^a   Gaspar, Laurie E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Hepatic irradiation; Liver metastases; Oligometastases; Phase I trial; Stereotactic body radiation therapy (SBRT)

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; PATIENT TREATMENT; TOXICITY; TUMORS;

DOSE LIMITING TOXICITY; INTESTINAL TOXICITY; LIVER METASTASES; STEREOTACTIC BODY RADIATION THERAPY (SBRT);

RADIOTHERAPY;

ANTIEMETIC AGENT; DEXAMETHASONE; GRANISETRON; ONDANSETRON;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL CANCER; ENTEROPATHY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER FUNCTION; LIVER METASTASIS; LIVER TOXICITY; MALE; MULTICENTER STUDY; MULTIPLE CANCER; NAUSEA; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE; TUMOR VOLUME;

ADULT; AGED; ANTIEMETICS; COHORT STUDIES; DOSE FRACTIONATION; FEMALE; HUMANS; KIDNEY; LIVER; LIVER NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SPINAL CORD;

EID: 22044432901     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.01.002     Document Type: Article

References (25)

1. L. Potters, M. Steinberg, C. Rose American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guidelines for the performance of stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 60 2004 1026 1032
2. B.D. Kavanagh R.D. Timmerman Stereotactic body radiation therapy 2005 Lippincott Williams & Wilkins New York
3. T.J. Gayowksi, S. Iwatsuki, J.R. Madariaga Experience in hepatic resection for metastatic colorectal cancer Analysis of clinical and pathological risk factors Surgery 116 1994 703 711
4. C.B. Rosen, D.M. Nagorney, H.F. Taswell Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma Ann Surg 216 1992 492 505
5. B. Nordlinger, R. Parc, E. Delva Hepatic resection for colorectal liver metastases Ann Surg 205 1987 256 263
6. Y. Fong, A.M. Cohen, J.G. Forter Liver resection for colorectal metastases J Clin Oncol 15 1997 938 946
7. A.E. Singletary, G. Walsh, J.N. Vauthey A role for curative surgery in the treatment of selected patients with metastatic breast cancer Oncologist 8 2003 241 251
8. K.K. Herfarth, J. Debus, M. Wannenmacher Stereotactic radiation therapy of liver metastases Update of the initial phase-I/II trial Front Radiat Ther Oncol 38 2004 100 105
9. J. Blomgren, I. Lax, H. Goranson Radiosurgery for tumors in the body Clinical experience using a new method J Radiosurg 1 1998 63 74
10. J. Wulf, U. Hadinger, U. Oppitz Stereotactic radiotherapy of targets in lung and liver Strahlenther Onkol 177 2001 645 655
11. R. Timmerman, L. Papiez, R. McGarry Extracranial stereotactic radioablation Results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955
12. S.H. Benedict, P.S. Lin, R.D. Zwicker The biological effectiveness of intermittent irradiation as a function of overall treatment time Development of correction factors for linac-based stereotactic radiotherapy Int J Radiat Oncol Biol Phys 37 1997 765 769
13. J.F. Fowler, J.S. Welsh, S.P. Howard Loss of biological effect in prolonged fraction delivery Int J Radiat Oncol Biol Phys 159 2004 242 249
14. R.J. Yeas, A. Kalend Local stem cell depletion model for radiation myelitis Int J Radiat Oncol Biol Phys 14 1988 1247 1259
15. C. Penna, B. Nordlinger Colorectal metastasis (liver and lung) Surg Clin North Am 82 2002 1075 1090
16. A.H. Russell, C. Clyde, T.H. Wasserman Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases Results of the RTOG dose escalating protocol Int J Radiat Oncol Biol Phys 27 1993 117 123
17. J.F. Fowler The Linear-quadratic formula and progress in fractionated radiotherapy A review Br J Radiol 62 1989 679 694
18. T.E. Schefter, H.R. Cardenes, B.D. Kavanagh Stereotactic body radiation therapy for primary and metastatic liver tumors B.D. Kavanagh R.D. Timmerman Stereotactic body radiation therapy 2005 Lippincott Williams & Wilkins New York
19. K.K. Herfarth, H. Hof, M.L. Bahner Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors Int J Radiat Oncol Biol Phys 57 2003 444 451
20. I. Lax, H. Blomgren, I. Nüslund Stereotactic radiotherapy of malignancies in the abdomen Methodological aspects Acta Oncol 33 1994 677 683
21. B.D. Kavanagh, R.D. Timmerman, S.H. Benedict How should we describe the radiobiologic effect of extracranial stereotactic radiosurgery Equivalent uniform dose or tumor control probability? Med Phys 30 2003 321 324
22. H. Romm, G. Stephan Dose dependency of FISH-detected translocations in stable and unstable cells after Cs gamma irradiation of human lymphocytes in vitro Cytogenet Genome Res 104 2004 162 167
23. L.A. Dawson, D. Normolle, J.M. Balter Analysis of radiation-induced liver disease using the Lyman NTCP model Int J Radiat Oncol Biol Phys 53 2002 810 821
24. A. Jackson, R.K. Ten Haken, J.M. Robertson Analysis of clinical complication data for radiation hepatitis using a parallel architecture model Int J Radiat Oncol Biol Phys 31 1995 883 891
25. J.F. Fowler, W.A. Tome, J.S. Welsh Estimation of required doses in stereotactic body radiation therapy B.D. Kavanagh R.D. Timmerman Stereotactic body radiation therapy 2005 Lippincott Williams & Wilkins New York